
Help Others Discover – Click to Share!
More than 400,000 new cancer cases and approximately 170,000 cancer deaths are reported annually across the UK. In England, 78.6% of patients received a diagnosis or all-clear within 28 days in August 2026, while performance against the 62-day referral-to-treatment standard stood at 71.9%. The National Cancer Plan has set an 85% target for the 62-day standard by March 2029, alongside an ambition for 75% five-year cancer survival by 2035. These figures highlight the pressure on cancer services to coordinate referrals, diagnostics, clinical assessments, treatment decisions and follow-up.
Cellma, an integrated EHR ecosystem from RioMed Technologies, supports this need for connected cancer care. By bringing together electronic clinical records, patient administration, referrals, appointments, medication management, patient portal capabilities and reporting, Cellma provides a digital environment for coordinating information across healthcare services. Its interoperability capabilities also support connections with external diagnostic applications and relevant NHS services. This aligns with the NHS 10 Year Health Plan’s shift from analogue to digital care, including its direction towards connected records and greater use of the NHS App.
Cancer treatment involves several clinical teams, departments and care settings. A patient may move from a GP referral to a specialist consultation, imaging, biopsy, histopathology, an MDT (multidisciplinary team) discussion and a treatment plan. Each stage generates clinical information that must be available to the professionals responsible for the next decision.
However, managing this pathway can create operational challenges:
Patient information across different systems Clinicians may need to access previous diagnoses, medication history, allergies and investigation reports from multiple applications. | Referral and appointment delays Manual handovers, incomplete referral details and scheduling difficulties can affect pathway coordination. |
| |
Diagnostic information gaps Imaging, pathology and laboratory results may be held in separate specialist systems. | MDT coordination Consultants and other specialists need relevant clinical records and investigation information before discussing a patient’s case. |
| |
Medication management Prescribing information, medication changes and allergies must be documented and accessible to authorised professionals. | Patient communication Patients need clear information about appointments, available results and their ongoing care. |
| |
Limited operational visibility Service managers need reliable information to monitor referrals, appointment activity and pathway performance. |
|
An EHR must therefore do more than replace paper records. It must support the workflows that connect different stages of cancer care. This is where Cellma’s integrated capabilities become relevant.
Cellma brings clinical and administrative workflows into a connected EHR ecosystem. Its configurable capabilities can support the information requirements of cancer services, from initial referral to ongoing follow-up.
1. Connected Electronic Clinical Records
Cancer patients may have complex medical histories, previous procedures, ongoing medication and investigations carried out by different providers. Having relevant information available during a consultation or clinical review is essential.
Cellma supports electronic clinical records and configurable clinical documentation, allowing healthcare organisations to structure records around their service and specialty requirements.
Clinical teams can document and access relevant information, including:
Cellma’s configurable clinician templates can be tailored to the documentation requirements of different specialties. This supports consistent record-keeping while allowing clinical teams to capture information relevant to their practice.
With authorised access to a more connected clinical record, professionals can review documented information without relying solely on manual requests or paper-based handovers.
2. Referral and Appointment Management
Cancer pathways often begin with an urgent suspected cancer referral. From there, patients may require specialist consultations, diagnostic appointments, treatment planning sessions and follow-up reviews.
Cellma supports Patient Administration System (PAS) workflows, referral management and appointment scheduling within its wider EHR environment.
This can support healthcare teams with:
By connecting patient administration with clinical records, Cellma supports the administrative coordination required throughout the cancer pathway.
3. Integration with Diagnostic and Laboratory Systems
Cancer diagnosis and treatment planning depend on information from several diagnostic services. Imaging, biopsy, histopathology and laboratory investigations generate results that clinicians need to review as part of patient assessment.
These services frequently operate through specialist applications. An EHR must therefore support interoperability rather than function as an isolated system.
Cellma supports integration with external healthcare applications through standards and interfaces such as HL7, FHIR and REST APIs. Depending on implementation requirements, connections can include:
For example, where a pathology or imaging system is integrated, relevant diagnostic information can be exchanged with the wider clinical environment. This helps authorised professionals access information required for clinical review.
Radiology, pathology and laboratory diagnostics remain specialist applications; Cellma supports their connection through configured interfaces. This distinction is important when assessing an EHR for cancer services.
4. Medication Management and e-Prescribing
Cancer treatment can involve complex medication requirements, supportive medicines, prescription changes and ongoing medication reviews. Accurate medication documentation is important when patients move between specialists and care settings.
Cellma supports medication management and e-prescribing as part of its integrated EHR capabilities.
Its medication workflows can support:
For specialist oncology services, chemotherapy and Systemic Anti-Cancer Therapy (SACT) prescribing requirements must be assessed separately against clinical protocols, governance arrangements and the organisation’s dedicated prescribing systems. Cellma’s medication capabilities should be configured and validated according to the service’s requirements.
5. Supporting MDT Meetings and Clinical Documentation
MDT meetings bring together professionals such as oncologists, surgeons, radiologists, pathologists, specialist nurses and other clinicians to review cases and discuss treatment options.
Preparing for these discussions requires access to relevant patient history, investigation information, previous treatment details and clinical assessments.
Cellma supports this process through accessible electronic records and structured clinical documentation. Where external diagnostic applications are connected, relevant information can be made available through the configured integration workflow.
Teams can use the clinical record to review documented information and maintain records of consultations, decisions and subsequent care activities.
Cellma does not replace the MDT process or specialist clinical judgement. It supports the information management around these discussions, helping teams work with accessible and appropriately documented records.
6. Patient Portal and NHS App Integration
Cancer treatment can involve repeated consultations, diagnostic appointments, treatment sessions and follow-up reviews. Patients need accessible information to understand and manage their interactions with healthcare services.
Cellma’s patient-facing digital capabilities support access to appropriate health information and service interactions through its portal ecosystem.
Depending on the configuration and services enabled, patients may be able to:
Cellma also supports integration with the NHS App, subject to the required NHS interfaces, approvals and implementation scope.
The NHS App provides a wider digital access point for NHS services, while a hospital patient portal can offer organisation-specific functions. Integration can help connect these digital experiences, allowing patients to access supported services through the relevant platform.
For cancer services, this is particularly relevant when patients need information about appointments, available records and ongoing care. It also supports the NHS direction towards more accessible digital services and connected patient information.
7. Reporting, Analytics and Service Oversight
Cancer service managers need visibility of operational activity to understand demand, monitor workloads and review pathway performance.
Cellma’s reporting and analytics capabilities can support service oversight by using information captured across relevant clinical and administrative workflows.
Depending on implementation and reporting configuration, teams can review:
This information can support internal performance reviews, resource planning and the identification of areas requiring further operational attention.
For organisations assessing how an EHR improve cancer treatment, reporting should be considered alongside clinical documentation and interoperability. Reliable operational information is an important part of managing cancer services.
For NHS organisations, an EHR must support more than clinical functionality. It must also address interoperability, information governance, technical security and clinical safety.
Cellma’s UK healthcare integration landscape includes connections and compatibility with relevant NHS systems and services, subject to implementation and interface requirements.
NHS system or standard | Relevance to healthcare services |
NHS App | Patient-facing digital access and engagement |
NHS Spine | National infrastructure for NHS information exchange |
GP Connect | Access to relevant GP clinical information |
Personal Demographics Service (PDS) | Patient demographic information |
Summary Care Record (SCR) | Access to relevant summary care information |
Electronic Referral Service (e-RS) | Electronic referral and booking workflows |
Electronic Prescription Service (EPS) | Electronic prescription services |
Care Identity Service 2 (CIS2) | Secure authentication for healthcare professionals |
Cellma’s interoperability framework also includes relevant standards and technologies such as:
The exchange of cancer-related information involves sensitive clinical data. Appropriate access controls, security measures and governance processes are therefore essential.
Cellma’s relevant UK assurance and security framework includes:
Cellma also supports role-based access controls, multi-factor authentication and audit trails to help manage access to sensitive clinical information and maintain accountability.
These standards and frameworks serve different purposes. Some govern information exchange, while others address data protection, cyber security, clinical safety and digital technology assurance. Their applicability and supporting evidence must be assessed against the specific deployment and NHS organisation’s requirements.
The value of a connected EHR lies in how its capabilities support everyday clinical and operational requirements.
Common challenge | Cellma capability |
Clinical information held across applications | Electronic clinical records and external system integrations |
Referral and appointment coordination | PAS, referral management and scheduling |
Diagnostic information held in specialist systems | HL7/FHIR-based integration capabilities |
Medication information across care settings | Medication management and e-prescribing |
MDT preparation and documentation | Accessible clinical records and structured documentation |
Patient access to information | Patient portal capabilities and NHS App integration |
Limited visibility of service activity | Reporting, analytics and business intelligence |
Sensitive clinical information | Role-based access, authentication and audit trails |
Cellma connects these capabilities within one wider EHR ecosystem. Healthcare organisations can configure workflows according to their clinical, administrative and operational requirements, while integrating with external applications where needed.
This is how an EHR improve cancer treatment strategy can address information gaps and support the coordination of the people, systems and processes involved in cancer care.
The NHS 10 Year Health Plan places digital access and connected information at the centre of its long-term direction for healthcare. The National Cancer Plan for England also sets clear ambitions for faster diagnosis, timely treatment and improved survival.
For cancer services, meeting these ambitions involves more than increasing diagnostic capacity. Teams also need access to relevant clinical information, coordinated referrals and appointments, connected diagnostic systems and reliable operational reporting.
Cellma supports these requirements through an integrated EHR ecosystem that brings together clinical records, PAS, referrals, appointments, medication management, patient portal capabilities, analytics and interoperability.
It is not about replacing specialist oncology teams or diagnostic applications. It is about connecting the information and workflows that support them.
Beyond diagnosis. Beyond individual appointments. Connected cancer care with Cellma.
Discover how Cellma can support your organisation’s cancer care coordination requirements. Contact RioMed Technologies to discuss your EHR requirements or arrange a demonstration.
Recent Blogs
Let’s transform healthcare together. Speak with RioMed for a tailored solution.
Cellma supports clinical records, referrals, appointments, medication management, patient communication and reporting. Its integration capabilities can also connect external diagnostic systems, subject to implementation requirements.
Cellma supports integration with relevant NHS services, including the NHS App, Spine, GP Connect, e-RS, PDS, SCR, EPS and CIS2, subject to the required interfaces, approvals and deployment scope.
Yes. Cellma supports integration with external diagnostic applications using technologies and standards such as HL7 and FHIR. The specific systems and information exchanged depend on the interface requirements and implementation.